HomeCompareARAV vs PM

ARAV vs PM: Dividend Comparison 2026

ARAV yields 4987.53% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ARAV wins by $60726414423802.54M in total portfolio value
10 years
ARAV
ARAV
● Live price
4987.53%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60726414423802.59M
Annual income
$58,422,163,401,288,310,000.00
Full ARAV calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — ARAV vs PM

📍 ARAV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodARAVPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ARAV + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ARAV pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ARAV
Annual income on $10K today (after 15% tax)
$423,940.15/yr
After 10yr DRIP, annual income (after tax)
$49,658,838,891,095,065,000.00/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, ARAV beats the other by $49,658,838,891,095,065,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ARAV + PM for your $10,000?

ARAV: 50%PM: 50%
100% PM50/50100% ARAV
Portfolio after 10yr
$30363207211901.32M
Annual income
$29,211,081,700,644,155,000.00/yr
Blended yield
96.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

ARAV
Analyst Ratings
8
Buy
9
Hold
1
Sell
Consensus: Hold
Price Target
$0.25
+523.4% upside vs current
Range: $0.25 — $0.25
Altman Z
-90.4
Piotroski
4/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ARAV buys
0
PM buys
0
No recent congressional trades found for ARAV or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricARAVPM
Forward yield4987.53%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$60726414423802.59M$49.6K
Annual income after 10y$58,422,163,401,288,310,000.00$2,492.02
Total dividends collected$60570499970588.68M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldBuy
Analyst price target$0.25$194.30

Year-by-year: ARAV vs PM ($10,000, DRIP)

YearARAV PortfolioARAV Income/yrPM PortfolioPM Income/yrGap
1← crossover$509,453$498,753.12$11,648$408.29+$497.8KARAV
2$24,291,968$23,746,853.30$13,589$495.90+$24.28MARAV
3$1,084,224,114$1,058,231,708.37$15,877$603.21+$1084.21MARAV
4$45,302,256,588$44,142,136,785.73$18,580$734.88+$45302.24MARAV
5$1,772,207,810,855$1,723,734,396,305.83$21,781$896.75+$1772207.79MARAV
6$64,916,695,091,411$63,020,432,733,796.11$25,578$1,096.12+$64916695.07MARAV
7$2,226,904,004,397,647$2,157,443,140,649,837.00$30,092$1,342.17+$2226904004.37MARAV
8$71,550,063,790,460,920$69,167,276,505,755,440.00$35,470$1,646.46+$71550063790.43MARAV
9$2,153,505,628,518,013,700$2,076,947,060,262,220,500.00$41,892$2,023.58+$2153505628517.97MARAV
10$60,726,414,423,802,585,000$58,422,163,401,288,310,000.00$49,578$2,492.02+$60726414423802.54MARAV

ARAV vs PM: Complete Analysis 2026

ARAVStock

Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of platinum- resistant recurrent ovarian cancer; and in Phase Ib/II clinical trial for the treatment of clear cell renal cell carcinoma and pancreatic adenocarcinoma. The company also develops AVB-S6, a soluble Fc-fusion protein to block the activation of the GAS6-AXL signaling pathway. It has a strategic collaboration agreement with WuXi Biologics (Hong Kong) Limited to develop novel high-affinity bispecific antibodies targeting cancer and fibrosis; and license agreement with 3D Medicines Inc. to develop products that contain batiraxcept as the sole drug substance for the treatment of human oncological diseases in mainland China, Taiwan, Hong Kong, and Macau. The company was formerly known as Versartis, Inc. and changed its name to Aravive, Inc. in October 2018. Aravive, Inc. was incorporated in 2008 and is headquartered in Houston, Texas.

Full ARAV Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this ARAV vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ARAV vs SCHDARAV vs JEPIARAV vs OARAV vs KOARAV vs MAINARAV vs MOARAV vs BTIARAV vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.